Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.88 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,587
Open 24.88
Bid (Size) 24.91 (600)
Ask (Size) 24.92 (100)
Prev. Close 24.88
Today's Range 24.88 - 24.88
52wk Range 20.91 - 27.69
Shares Outstanding 5,606,688,356
Dividend Yield 6.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded... 
Via MarketMinute
News headline image
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
As the biotech sector closes out a transformative 2025, one name has risen to the top of every institutional investor's watchlist: Abivax (NASDAQ: ABVX). Following a year of stellar clinical results... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
-6.5%
-6.5%
1 Month
-1.3%
-1.3%
3 Month
+3.1%
+3.1%
6 Month
+2.3%
+2.3%
1 Year
-6.9%
-6.9%

More News

Read More
News headline image
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
Via MarketMinute
Topics Economy
Pfizer Confirms Death Of Patient Enrolled In Hemophilia Drug Study ↗
Via Stocktwits
News headline image
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
Pfizer Reports Patient Death In Marstacimab Hemophilia Extension Study ↗
Via Benzinga
News headline image
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
Via MarketMinute
Topics Economy
News headline image
The Great Consolidation: Why 2026 is Set to Become the 'Year of the Mega-Deal'
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond
Via PredictStreet
Topics Economy Intellectual Property
News headline image
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? ↗
Via The Motley Fool
MarketBeat Week in Review – 12/15 - 12/19 ↗
Via MarketBeat
News headline image
Better Buy in 2026: Pfizer or Merck? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗
Via Investor's Business Daily
Topics Government Stocks
News headline image
Friday's session: most active stock in the S&P500 index ↗
Via Chartmill
News headline image
Down 80%, Should You Buy the Dip on Moderna? ↗
Via The Motley Fool
News headline image
1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm
Via StockStory
Topics Stocks
News headline image
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗
Via The Motley Fool
News headline image
Better Buy in 2026: Pfizer or Eli Lilly? ↗
Via The Motley Fool
Topics World Trade
News headline image
Flying Blind: How the Record 43-Day Shutdown Blinded the Fed and Rattled Global Markets
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony
Via PredictStreet
Topics Economy World Trade
News headline image
Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry ↗
Via Benzinga

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.88
When was Pfizer last traded?
The last trade of Pfizer was at 12/23/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 139.49B
How many shares of Pfizer are outstanding?
Pfizer has 139B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.